Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M239Revenue $M1.9Net Margin (%)-2,469.5Z-Score-20.7
Enterprise Value $M231EPS $-1.6Operating Margin %-1,837.8F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-2,469.5Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio4.5Cash flow > EarningsY
Price/Sales1055-y EBITDA Growth Rate %-37.7Current Ratio5.2Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-235.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M31.6ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with ALIM

Number of guru portfolios checked: 54.

No Entry found!

ALIM is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ALIM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Holland DavidSVP of Sales and Marketing 2014-04-01Sell10,000$8.01-21.22 view
Caballa SusanSee Remarks 2014-03-04Sell8,931$7.01-9.99 view
Myers C. DanielPresident and CEO 2014-03-04Sell22,775$7.1-11.13 view
Holland DavidSVP of Sales and Marketing 2014-03-04Sell10,000$6.84-7.75 view
EISWIRTH RICHARD S JRCOO and CFO 2014-01-17Sell50,000$8.1-22.1 view
Domain Partners VI, L.P.10% Owner 2014-01-16Sell296,760$6.39-1.25 view
DP VI Associates, L.P.10% Owner 2014-01-16Sell3,240$6.39-1.25 view
Polaris Venture Management Co 2013-07-17Sell122,937$4.831.46 view
Domain Partners VI, L.P.10% Owner 2013-06-20Sell10,516$5.0125.95 view
DP VI Associates, L.P.10% Owner 2013-06-20Sell114$5.0125.95 view

Press Releases about ALIM :

    Quarterly/Annual Reports about ALIM:

    News about ALIM:

    Articles On GuruFocus.com
    comment on ALIM Mar 02 2013 
    Alimera Sciences Inc. (ALIM) President and CEO C. Daniel Myers sells 45,523 Shares Mar 16 2011 
    The Most Speculative Stocks on the Market: Harbinger, Kaching Kaching, Alimera Sciences, Star Scient Jul 29 2010 

    More From Our Partners
    Alimera/pSivida Seek FDA Approval for Iluvien - Analyst Blog Apr 15 2014 - ZACKS

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Hide